Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model

Kidney International

Volumn 84, Issue 4, 2013, Pages 722-732

  Kohei, Naoki ^a   Tanabe, Tatsu ^a   Horita, Shigeru ^a   Omoto, Kazuya ^a   Ishida, Hideki ^a   Yamaguchi, Yutaka ^b   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Yamaguchi's Pathology Laboratory   (Japan)

Author keywords

animal models; antibody mediated rejection; C4d staining; donor specific antigen; kidney transplantation

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; CREATININE; DONOR SPECIFIC ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE ANTIBODY MEDIATED REJECTION; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY MEDIATED REJECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELL INFILTRATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; EDEMA; ENDARTERITIS; GLOMERULITIS; GLOMERULUS CAPILLARY; GRAFT SURVIVAL; HISTOPATHOLOGY; INFLAMMATION; INTIMAL ARTERITIS; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CAPILLARY; KIDNEY TUBULE DISORDER; MALE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT MODEL; SENSITIZATION; SEQUENTIAL ANALYSIS; SKIN TRANSPLANTATION; SURGICAL RISK; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUBULITIS;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CAPILLARIES; COMPLEMENT C4B; CYTOKINES; GRAFT REJECTION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MODELS, ANIMAL; PEPTIDE FRAGMENTS; RATS; RATS, INBRED BN; RATS, INBRED LEW; SKIN TRANSPLANTATION; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 84885329053     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.117     Document Type: Article

References (62)

1. Murata K, Baldwin WM. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibodymediated rejection. Transplant Rev (Orlando) 2009; 23: 139-150.
2. Kieran N, Wang X, Perkins J et al. Combination of peritubular C4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol 2009; 20: 2260-2268.
3. Cosio FG, Gloor JM, Sethi S et al. Transplant glomerulopathy. Am J Transplant 2008; 8: 492-496.
4. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807-817.
5. Takemoto SK, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantationAm J Transplant 2004; 4: 1033-1041.
6. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
7. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760.
8. Loupy A, Suberbielle-Boissel C, Hill GS et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561-2570.
9. Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010; 15: 42-48.
10. Haas M. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Clin Nephrol 2011; 75: 271-278.
11. Ishida H, Hirai T, Kohei N et al. Significance of qualitative and quantitative evaluations of anti-HLA antibodies in kidney transplantation. Transpl Int 2011; 24: 150-157.
12. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-1056.
13. Lefaucheur C, Nochy D, Hill GS et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007; 7: 832-841.
14. Toki D, Ishida H, Setoguchi K et al. Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors. Am J Transplant 2009; 9: 567-577.
15. Burns JM, Cornell LD, Perry DK et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008; 8: 2684-2694.
16. Stegall MD, Gloor J, Winters JL et al. A comparison of plasmapheresis vs. high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006; 6: 346-351.
17. Ellyard JI, Avery DT, Phan TG et al. Antigen-selected, immunoglobulinsecreting cells persist in human spleen and bone marrow. Blood 2004; 103: 3805-3812.
18. Nagano H, Nadeau KC, Takada M et al. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation 1997; 63: 1101-1108.
19. Martin L, Guignier F, Mousson C et al. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003; 76: 395-400.
20. Adeyi OA, Girnita AL, Howe J et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol 2005; 14: 53-62.
21. Bickerstaff A, Pelletier R, Wang JJ et al. An experimental model of acute humoral rejection of renal allografts associated with concomitant cellular rejection. Am J Pathol 2008; 173: 347-357.
22. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338.
23. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208-2214.
24. Lederer SR, Kluth-Pepper B, Schneeberger H et al. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 2001; 59: 334-341.
25. Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 2002; 11: 609-618.
26. Feucht HE. Complement C4d in graft capillaries-the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3: 646-652.
27. Michaels PJ, Espejo ML, Kobashigawa J et al. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003; 22: 58-69.
28. Mengel M, Bogers J, Bosmans JL et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005; 5: 1050-1056.
29. Rodriguez ER, Skojec DV, Tan CD et al. Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005; 5: 2778-2785.
30. Seemayer CA, Gaspert A, Nickeleit V et al. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568-576.
31. Crary GS, Raissian Y, Gaston RC et al. Optimal cutoff point for immunoperoxidase detection of C4d in the renal allograft: results from a multicenter study. Transplantation 2010; 90: 1099-1105.
32. Haddy FJ. Vasomotion in systemic arteries, small vessels and veins determined by direct resistance measurements. Minn Med 1958; 41: 162-170.
33. Ionescu DN, Girnita AL, Zeevi A et al. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol 2005; 15: 63-68.
34. Murata K, Iwata T, Nakashima S et al. C4d deposition and cellular infiltrates as markers of acute rejection in rat models of orthotopic lung transplantation. Transplantation 2008; 86: 123-129.
35. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63: 1888-1893.
36. Jeannet M, Pinn VW, Flax MH et al. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970; 282: 111-117.
37. Gibson IW, Gwinner W, Brö cker V et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8: 819-825.
38. Kishore U, Reid KB. C1q Structure, function, and receptors. Immunopharmacology 2000; 49: 159-170.
39. Walport MJ. Complement-First of two parts. N Engl J Med 2001; 344: 1058-1066.
40. Walport MJ. Complement-Second of two parts. N Engl J Med 2001; 344: 1140-1144.
41. Chin C, Chen G, Sequeria F et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011; 30: 158-163.
42. Mathew M, Bolton WK. Linear C3 deposits on the tubular basement membrane in renal allograft biopsies. Am J Kidney Dis 1988; 12: 121-125.
43. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338.
44. Feucht HE, Felber E, Gokel MJ et al. Vascular deposition of complementsplit products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991; 86: 464-470.
45. Morgan BP, Gasque P. Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol 1997; 107: 1-7.
46. Sacks SH, Zhou W, Andrews PA et al. Endogenous complement C3 synthesis in immune complex nephritis. Lancet 1993; 342: 1273-1274.
47. Andrews PA, Finn JE, Lloyd CM et al. Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur J Immunol 1995; 25: 1087-1093.
48. Andrews PA, Zhou W, Sacks SH. Tissue synthesis of complement as an immune regulator. Mol Med Today 1995; 1: 202-207.
49. Conolly JK, Guy SP, Parrott NR. Cytokine gene expression and eicosonoid production in renal reperfusion injury. Transplant Proc 1995; 27: 2816.
50. Daemen MA, van de Ven MW, Heineman E et al. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation 1999; 67: 792-800.
51. Donnahoo KK, Shames BD, Harken AH et al. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999; 162: 196-203.
52. Koo DD, Welsh KI, Roake JA et al. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998; 153: 557-566.
53. Kuziel WA, Morgan SJ, Dawson TC et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 1997; 94: 12053-12058.
54. Yamaguchi Y, Ichiguchi O, Matsumura F et al. Enhanced expression of cytokine-induced neutrophil chemoattractant in rat hepatic allografts during acute rejection. Hepatology 1997; 26: 1546-1552.
55. Yadav SS, Howell DN, Gao W et al. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 1998; 275(6 Pt 1): G1341-G1352.
56. Shimizu Y, Newman W, Gopal TV et al. Four molecular pathways of T-cell adhesion to endothelial cells: roles of LFA-1, VCAM-1 and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 1991; 113: 1203-1212.
57. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
58. Taylor HR, Morris PJ. Skin grafting in rats. Am J Med Technol 1970; 36: 149-157.
59. Fujishiro J, Kudou S, Iwai S et al. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation. Transplantation 2006; 82: 804-812.
60. Wray DW, Baldwin WM III, Sanfilippo F. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion. Transplantation 1992; 53: 167-174.
61. Wray DW, Baldwin WM III, Sanfilippo F. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination. Transplantation 1993; 55: 1132-1138.
62. Schwartz A, Gaigalas AK, Wang L et al. Formalization of the MESF unit of fluorescence intensity. Cytometry B Clin Cytom 2004; 57: 1-6.